Scientific advice on commercially driven research in order to ensure the production of a marketable product.
Advice on the legislative and regulatory framework in terms of the Medicines and Related Substances Act 101 of 1965 and the Pharmacy Act 53 of 1974, both as amended.
Intellectual property law opinions, technical advice, expert evidence and portfolio management
Pharmalaw was established to provide the pharmaceutical industry with a legal partner who understands science and the impact of intellectual property rights and the regulatory environment on the commercialisation of medicines. A multidisciplinary insight is provided which bridges the gap between science, law and commerce. Pharmalaw functions in association with legal experts in the fields of intellectual property and customs and excise matters.